Asset Management One Co. Ltd. Has $60.24 Million Stock Position in CME Group Inc. $CME

Key Points

• Asset Management One Co. Ltd. increased its stake in CME Group Inc. by 2.6%, holding a total of 218,570 shares valued at approximately $60.24 million.
• CME Group recently announced a quarterly dividend of $1.25 per share, resulting in an annualized dividend of $5.00 with a yield of 1.9%.
• A consensus of analysts has assigned CME Group a rating of "Hold" with a consensus price target of $284.53, after various firms adjusted their target prices in recent reports.

Asset Management One Co. Ltd. raised its stake in shares of CME Group Inc. (NASDAQ:CME - Free Report) by 2.6% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 218,570 shares of the financial services provider's stock after purchasing an additional 5,557 shares during the quarter. Asset Management One Co. Ltd. owned 0.06% of CME Group worth $60,242,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors also recently added to or reduced their stakes in the company. Catalyst Capital Advisors LLC boosted its holdings in CME Group by 256.9% during the first quarter. Catalyst Capital Advisors LLC now owns 3,662 shares of the financial services provider's stock valued at $971,000 after purchasing an additional 2,636 shares in the last quarter. OMNI 360 Wealth Inc. bought a new position in shares of CME Group in the first quarter valued at approximately $367,000. Fulcrum Equity Management bought a new position in shares of CME Group in the first quarter valued at approximately $258,000. AIA Group Ltd raised its stake in shares of CME Group by 17.8% in the first quarter. AIA Group Ltd now owns 16,645 shares of the financial services provider's stock valued at $4,416,000 after acquiring an additional 2,510 shares during the last quarter. Finally, Insight Inv LLC bought a new position in shares of CME Group in the first quarter valued at approximately $2,712,000. 87.75% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of research firms have recently issued reports on CME. Oppenheimer lifted their target price on shares of CME Group from $300.00 to $303.00 and gave the company an "outperform" rating in a research note on Thursday, July 24th. JPMorgan Chase & Co. lifted their target price on shares of CME Group from $252.00 to $256.00 and gave the company an "underweight" rating in a research note on Tuesday, October 14th. Keefe, Bruyette & Woods lifted their target price on shares of CME Group from $283.00 to $287.00 and gave the company a "market perform" rating in a research note on Monday, October 13th. Wall Street Zen cut shares of CME Group from a "hold" rating to a "sell" rating in a research note on Sunday, July 13th. Finally, Raymond James Financial cut their target price on shares of CME Group from $309.00 to $307.00 and set an "outperform" rating for the company in a research note on Monday, October 13th. Eight research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and three have assigned a Sell rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of "Hold" and a consensus price target of $284.53.

Insider Buying and Selling at CME Group

In other CME Group news, Director William R. Shepard bought 262 shares of the company's stock in a transaction on Thursday, September 25th. The stock was bought at an average price of $265.19 per share, for a total transaction of $69,479.78. Following the transaction, the director owned 258,459 shares of the company's stock, valued at approximately $68,540,742.21. The trade was a 0.10% increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, insider Timothy Francis Mccourt sold 379 shares of the company's stock in a transaction on Tuesday, September 16th. The shares were sold at an average price of $259.83, for a total transaction of $98,475.57. Following the sale, the insider owned 9,508 shares of the company's stock, valued at $2,470,463.64. The trade was a 3.83% decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 13,043 shares of company stock worth $3,527,956. 0.30% of the stock is currently owned by insiders.

CME Group Stock Performance

CME stock opened at $268.90 on Friday. The company has a debt-to-equity ratio of 0.12, a current ratio of 1.02 and a quick ratio of 1.02. The company has a 50 day moving average price of $266.56 and a 200 day moving average price of $271.57. CME Group Inc. has a fifty-two week low of $213.94 and a fifty-two week high of $290.79. The stock has a market capitalization of $96.91 billion, a PE ratio of 26.06, a price-to-earnings-growth ratio of 6.16 and a beta of 0.41.

CME Group (NASDAQ:CME - Get Free Report) last released its earnings results on Wednesday, October 22nd. The financial services provider reported $2.68 EPS for the quarter, topping analysts' consensus estimates of $2.63 by $0.05. The firm had revenue of $1.54 billion during the quarter, compared to analyst estimates of $1.56 billion. CME Group had a net margin of 58.84% and a return on equity of 14.61%. The business's quarterly revenue was down 3.0% compared to the same quarter last year. During the same quarter in the previous year, the business earned $2.68 EPS. Analysts forecast that CME Group Inc. will post 10.49 EPS for the current year.

CME Group Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Thursday, September 25th. Shareholders of record on Tuesday, September 9th were given a dividend of $1.25 per share. The ex-dividend date was Tuesday, September 9th. This represents a $5.00 annualized dividend and a dividend yield of 1.9%. CME Group's payout ratio is presently 48.40%.

CME Group Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.